IMAGE ANALYSIS GROUP will be attending the World Medical Innovation Forum on September 22–23.

Public source

Publisher name

Public post

Excited to share that IMAGE ANALYSIS GROUP will be at the World Medical Innovation Forum on September 22–23! I'll be joining conversations with CEOs from leading pharma…

Log in to read the full post

Company

IMAGE ANALYSIS GROUP

Imaging | Clinical Trials | Powered by DYNAMIKA™ | Fueled by Expertise

Industry
Biotechnology Research
Location
London, GB
Company size
51–200 employees

About IMAGE ANALYSIS GROUP

Image Analysis Group (IAG) is a global imaging CRO and imaging core lab for biotech and pharma sponsors. IAG delivers end-to-end medical imaging services for clinical trials that use imaging to assess drug safety and efficacy, supporting Phase I to Phase IV studies in oncology, rheumatology, orthopedics, obesity, cardiology, hepatology, neurology, and rare disease. What is an imaging CRO? IAG designs and executes the imaging component of a clinical trial - from imaging endpoint strategy through to regulatory submission - using a centralized imaging core lab model. Imaging modalities supported: X-ray, DXA, CT, MRI, DCE-MRI, functional MRI, PET, PET/CT, PET/MR, SPECT, ultrasound, and cardiac safety imaging. Services: • Imaging endpoint strategy and protocol design - imaging biomarkers and scoring systems including RECIST, iRECIST, mRECIST, RANO, Sharp, van der Heijde, RAMRIS, OARSI, Kellgren–Lawrence, and PDFF; feasibility, sample size, and regulatory alignment with FDA, EMA, MHRA, and PMDA • Imaging Charter, Imaging Manual, Imaging Review Charter, and SOPs aligned to ICH-GCP and 21 CFR Part 11 • Site qualification, technologist training, positioning kits, and 24/5 multilingual site support • Secure DICOM image collection, transfer, de-identification, technical and protocol QC, and audit trail • Centralized independent radiological review by board-certified radiologists, with chronological, paired, and randomized reading paradigms and third-reader adjudication • Quantitative imaging and AI-based analysis via DYNAMIKA™, IAG's proprietary platform for automated quantification of synovitis, bone marrow edema, erosions, tumor volumetrics, perfusion, diffusion, and liver fat fraction • Regulatory support for IND, IMPD, NDA, BLA, and MAA submissions and FDA Type B and C meetings ISO 27001, ISO 9001, GDPR, HIPAA, and 21 CFR Part 11 compliant. Global operations across the UK, EU, US, and APAC. Contact IAG to scope your next imaging trial: contact@ia-grp.com

See more

Latest activity

6 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.